Light-mediated therapy aims to overcome both tumour cell uptake barriers and toxicity problems

Source: news.prnewswire.com Author: press release PCI Biotech Holding ASA, the Norwegian drug delivery company focusing on effective delivery of cancer therapeutics, today announced that the first patient has received treatment in the Phase I/II trial with the lead candidate Amphinex(R), which uses a new approach called photochemical internalisation. The patient was treated at the University College Hospital [...]